Research LettersUK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years
References (5)
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation
Lancet
(1996)The Collaborative ECMO trial: follow-up to 1 year of age
Pediatrice
(1998)
Cited by (175)
Comorbidities and Late Outcomes in Neonatal Pulmonary Hypertension
2024, Clinics in PerinatologyPediatric ECLS Neurologic Management and Outcomes
2023, Seminars in Pediatric SurgeryPersistent Pulmonary Hypertension
2023, Avery's Diseases of the NewbornNeonatal ECMO survivors: The late emergence of hidden morbidities – An unmet need for long-term follow-up
2022, Seminars in Fetal and Neonatal MedicineCitation Excerpt :In the UK Trial, impairment with or without disability was reported in 1 in 4 of the survivors at 1 year. At the four-year follow-up, a widening range of neurodevelopmental morbidities was becoming apparent with one-third (33%) experiencing hyperactivity or behavioral difficulties and 60% of survivors showing abnormal neuromotor function for age [42,44,45]. At the 7-year follow-up, a clearer profile of the learning difficulties and behavior problems became more evident, and the difficulties detectable at earlier assessment appeared to be predictive of later problems [45].
Long term outcome of babies with pulmonary hypertension
2022, Seminars in Fetal and Neonatal MedicineCitation Excerpt :ECMO allows time for the pulmonary hypertensive therapies to work, and for the primary lung disease to resolve without further ventilator-induced lung injury. This strategy has been remarkably effective as demonstrated by the clear results of the UK collaborative neonatal respiratory ECMO trial [35–37]. While ECMO may buy time, the ultimate outcome depends on a number of important factors and how they relate to one another.
Extracorporeal membrane oxygenation
2022, Goldsmith's Assisted Ventilation of the Neonate: An Evidence-Based Approach to Newborn Respiratory Care, Seventh Edition
See The Lancet website www.thelancet.com for a list of contributing members.
Further information available on at www.thelancet.com